| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1346226B1 Screening method based on siah-numb interaction |
| 05/31/2006 | EP1333845A4 Treatment of t cell disorders |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1248641B1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1115745B1 Purification of fibrinogen from fluids by precipitation and hydrophobic interaction chromatography |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1105410A4 Purification of blood clotting proteins |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | EP0915156B1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 05/31/2006 | EP0914437B1 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/31/2006 | EP0912204B1 Compositions for the treatment and repair of defects in cartilage using functional barrier |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | EP0888456B1 Prostate specific antigen oligo-epitope peptide |
| 05/31/2006 | EP0861321B1 Phosphopantetheinyl transferases and uses thereof |
| 05/31/2006 | EP0840789B1 Transketolase-related protein |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN1781019A Animal model simulating neurologic disease |
| 05/31/2006 | CN1780919A Methods and products based on oligomerization of stress proteins |
| 05/31/2006 | CN1780854A Insulin analogs having protracted time action |
| 05/31/2006 | CN1780853A Secreted protein family |
| 05/31/2006 | CN1780852A Group 1 mite polypeptide variants |
| 05/31/2006 | CN1780664A Methods for treating sinus headache |
| 05/31/2006 | CN1780642A Remedy for diabetes |
| 05/31/2006 | CN1780639A Angiotensin-converting enzyme inhibitory peptides |
| 05/31/2006 | CN1780638A Protein stabilization in solution |
| 05/31/2006 | CN1780637A Liquid, aqueous, pharmaceutical compositions of factor VII polypeptides |
| 05/31/2006 | CN1780636A Combined use of G-CSF with angiogenetic factor |
| 05/31/2006 | CN1780635A Preventives or remedies for hepatopathy |
| 05/31/2006 | CN1780634A Methods and compositions using gonadotropin hormone releasing hormone |
| 05/31/2006 | CN1780633A Pharmaceutical compositions for treating painful neuropathy and methods of treating same |
| 05/31/2006 | CN1780632A Therapy for primary and metastatic cancers |
| 05/31/2006 | CN1780608A Solid dosage form comprising desmopressin and method for manufacturing thereof |
| 05/31/2006 | CN1780607A Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 05/31/2006 | CN1780555A Nasal administration of the LH-RH analog leuprolide |
| 05/31/2006 | CN1778930A Fusion gene of provocative organ anti-Coccidium tenellum infection and its coding protein and use thereof |
| 05/31/2006 | CN1778929A Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof |
| 05/31/2006 | CN1778918A SiRNA for inhibiting Stat3 gene expression and preparation thereof |
| 05/31/2006 | CN1778916A Polypeptide with Beta-lactamase inhibiting activity and its coded DNA |
| 05/31/2006 | CN1778821A Granular leukocyte colony-stimulating factors coupling agent with chemical modification and production thereof |
| 05/31/2006 | CN1778820A Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 05/31/2006 | CN1778819A Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 05/31/2006 | CN1778816A Human cell surface membrane molecule and use thereof |
| 05/31/2006 | CN1778387A Health-care products for improving anamnesis and preventing brain function catagenesis and its preparation thereof |
| 05/31/2006 | CN1778386A Injection of troxerutin and encephalic protein hydrolysate |
| 05/31/2006 | CN1778367A Rapid-acting meridian ease pain cream and preparation thereof |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/31/2006 | CN1257917C Process for preparing collagen active polypeptide from avian animal tissue |
| 05/31/2006 | CN1257916C Parathyroid hormone analog and its preparing process by recombination |
| 05/31/2006 | CN1257915C Adherence peptide specific to tissue of liver cancer obtained through sieve method in rivo and usage |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/31/2006 | CN1257749C Sheep lamb increasing essence |
| 05/31/2006 | CN1257708C Modified water-soluble medicine and vaccine embedded macromolecule microsphere preparation method |
| 05/30/2006 | US7053194 Compositions and methods for p53-mediated repression of gene expression |
| 05/30/2006 | US7053193 Up-regulated breast cancer transcription factor amino acid sequence |
| 05/30/2006 | US7053190 Antibody for use in the treatment and diagnosis of immunological and lysomal defect |
| 05/30/2006 | US7053186 Protein for use in diagnosis and treatment of cancer |
| 05/30/2006 | US7053185 contacting alpha-lactalbumin (in molten globule-like state) with fatty acids and lipids found in a milk fraction containing casein obtained from humans; antibacterial agents; anticancer agents |
| 05/30/2006 | US7053184 Expression vector coding polypeptide with thrombin proteolytic sequences; for use in evaluating ligand binding and signal transduction |
| 05/30/2006 | US7053181 Canine and feline B7-2 proteins, compositions and uses thereof |
| 05/30/2006 | US7053180 Isolated islet beta-cell two-pore domain potassium channel |
| 05/30/2006 | US7053179 Inhibits hiv infection of cells |
| 05/30/2006 | US7053178 biotinylation; for inhibiting activity of anti-beta-2-glycoprotein 1 monoclonal antibodies in vitro |
| 05/30/2006 | US7053177 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
| 05/30/2006 | US7053176 Combination of C1-INH and lung surfactant for the treatment of respiratory disorders |
| 05/30/2006 | US7053175 Delta -Z-TrpGlyCys- Theta -CysTyrThrSer- Omega, ( Delta represents a biotinyl radical, a biocytinyl radical, a hydrogen atom, an acetyl (CH3CO ) radical, an aliphatic chain which may contain one or two thiol, aldehyde or amine functional groups, and Z= a peptide sequence) |
| 05/30/2006 | US7053081 Cyclic malonamides as inhibitors of A-β protein production |
| 05/30/2006 | US7053062 Compositions and methods for inducing gene expression |
| 05/30/2006 | US7053058 For inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053055 Compounds of unstable DP IV-inhibitors |
| 05/30/2006 | US7053054 Purified LH |
| 05/30/2006 | US7053053 for diagnostic/therapeutic/prophylactics for neurodegenerative diseases, brain dysfunctions, cancers, gastrointestinal/circulatory/endocrine diseases and cell death; genetic engineering |
| 05/30/2006 | US7053052 for enhancing immunogenicity activity of tumor cells; tumor/drug targets |
| 05/30/2006 | US7053051 depolymerization of collagen; heart valves |
| 05/30/2006 | US7053050 administering erythropoietin receptor antagonist or mimetics thereof |
| 05/30/2006 | US7053049 Cardiovascular disorders; anticholesterol agents; administering apolipoproteins and phospholipids mixture |
| 05/30/2006 | US7053047 Cyclic pentapeptides and their preparation |
| 05/30/2006 | US7053046 Peptide activators of VEGF |
| 05/30/2006 | US7053045 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 05/30/2006 | US7053044 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 05/30/2006 | US7053043 host-versus-graft disease (HVGD) and graft-versus-host disease (GVHD); from human leukocyte antigen matched and unmatched allogeneic human donors |
| 05/30/2006 | US7053041 Methods and compositions useful for inhibition of αvβ5mediated angiogenesis |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052900 Saccharomyces cerevisiae yeast strain with functional expression of a Glut transporter |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052895 nucleotide sequences that code amino acid sequences having hydrolase enzyme activity, used for medical diagnosis, for prophylaxis of diseases and drug screening; bioassay |
| 05/30/2006 | US7052894 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 05/30/2006 | US7052893 Peptide for use in human therapeutics and diagnostic compositions |
| 05/30/2006 | US7052892 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 05/30/2006 | US7052889 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
| 05/30/2006 | US7052888 ACTR-1 a novel human acyltransferase and uses thereof |